Israeli (TA) Growth Pharmaceuticals & Biotech Stocks

UPDATED Jul 20, 2024

Discover Israeli Pharmaceuticals & Biotech Growth Stocks that are on the TA. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

26 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

CANF

Can-Fite BioPharma
₪0.05230.0%44.4%₪76.2mn/aPS31.8xE59.6%n/a

BLRX

BioLineRx
₪0.1911.1%-50.3%₪247.0mn/aPS5.4xE55.1%n/a

EVGN

Evogene
₪2.26-2.1%-44.9%₪114.6mn/aPS3.4xE35.0%n/a

KMDA

Kamada
₪20.96-4.0%11.4%₪1.2bn/aPE26.5xE21.6%n/a

PPBT

Purple Biotech
₪0.163.9%-65.9%₪48.5mn/aPB0.4xE4.3%n/a

NXTG

Nextage Therapeutics
₪0.66-3.5%-3.6%₪22.2mn/an/an/an/a

REKA

Rekah Pharmaceutical Industry
₪15.70-1.4%-12.9%₪172.1mn/aPB1.1xn/a0%

BONS

Bonus BioGroup
₪0.150%-7.3%₪179.9mn/aPB8.1xn/an/a

CBI

Clal Biotechnology Industries
₪0.41-17.0%-20.2%₪67.6mn/aPS625.9xn/a0%

UNVO

Univo Pharmaceuticals
₪0.0930%-94.3%₪2.8mn/aPB0.2xn/an/a

BOLT

BioLight Life Sciences
₪4.790.8%-26.1%₪22.3mn/aPS188.9xn/an/a

PLNT

PlantArc Bio
₪2.930%-40.2%₪9.7mn/aPS2xn/an/a

GRAC

Grace Breeding
₪14.650.7%33.4%₪58.1mn/aPS125.5xn/an/a

KDST

Kadimastem
₪5.96-4.2%-16.0%₪24.3mn/aPE-2.1xn/an/a

MTLF

Matricelf
₪3.48-2.5%-18.3%₪56.2mn/an/an/an/a

NXGN

Nextgen Biomed
₪1.03-10.4%-63.2%₪9.0mn/aPE-0.6xn/an/a

SEMG

Seach Medical Group
₪1.522.5%-11.5%₪51.3mn/aPB0.7xn/an/a

PMCN-M

Pharmocann Global
₪2.40-0.2%60.2%₪6.1mn/aPB8.1xn/an/a

GFC-M

G.F.C Green Fields Capital
₪12.5010.2%27.6%₪123.2mn/aPE8xn/an/a

TKUN

Tikun Olam-Cannbit Pharmaceuticals
₪0.362.0%8.7%₪29.4mn/aPB0.7xn/an/a

SMAG

Smart Agro -
₪4.230%-21.1%₪9.1mn/aPB0.2xn/an/a

HDST-M

HBL - Hadasit Bio-Holdings
₪0.38-0.3%-70.0%₪4.2mn/aPB0.7xn/an/a

XTLB

XTL Biopharmaceuticals
₪0.0913.4%160.0%₪49.6mn/aPB5xn/an/a

CSURE-M

Y.B Urban Renewal - Residential Development
₪16.16-12.6%304.0%₪50.7mn/aPS4xn/an/a
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.